Andrology & Gynecology: Current ResearchISSN: 2327-4360

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Androl Gynecol Curr Res Vol: 4 Issue: 1

Gestational Trophoblastic Neoplasia Series of 17 Cases

Slimani Q*, Alaoui PF, Jayi S, Chaara H, Bouguern H and Malhouf MA
Department of Gynaecology and Obstetric II, Teaching Hospital Hassan II, Fez, Morocco
Corresponding author : Slimani Q
Department of gynaecology & obstetric II, Teaching Hospital Hassan II, Fez, Berkane, Morocco
Tel: 012572475875
E-mail: sliwaf-80@hotmail.fr
Received: December 03, 2015 Accepted: March 07, 2016 Published: March 14, 2016
Citation: Slimani Q, Alaoui PF, Jayi S, Chaara H, Bouguern H, et al. (2016) Gestational Trophoblastic Neoplasia Series of 17 Cases. Androl Gynecol: Curr Res 4:1. doi:10.4172/2327-4360.1000144

Abstract

Gestational Trophoblastic Neoplasia Series of 17 Cases

Gestational trophoblastic neoplasia comprises a unique group of human neoplastic diseases that derive from fetal trophoblastic tissues. They are proliferative as well as degenerative disorders of placental elements and include complete or partial hydatiform mole (90%), invasive mole (5-8%) which could also be metastatic, villous or a villous choriocarcinoma (1-2%), and placental site tumor (1-2%). During the study period of 5 years, from January 2009 to December 2013, there were 17 cases analyzed retrospectively. Invasive mole and choriocarcinoma, which make up the vast majority of these tumors, always produce substantial amounts of human chorionic gonadotropin (hCG)..

Keywords: Gestational trophoblastic neoplasia; Gestational trophoblastic disease; Human chorionic gonadotropin; Hydatidiform mole; Drug therapy

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

Associations

open access